SR

Sridhar Raju Gadiraju

Active Director Director DIN 09170337
DIN 09170337 First appointment May 2021 Primary industry Chemicals and Materials
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2021
Shareholding value •••• Premium profile

About Sridhar Raju Gadiraju

Data last updated:

Sridhar Raju Gadiraju is a Director at Sahithi Pharma Private Limited (since 2021). The company operates in Chemicals and Materials. Sahithi Pharma Private Limited reported revenue of ₹34.27 Cr (FY 2025).

DIN 09170337
Primary Designation Director
Industry Chemicals and Materials
First Appointment 11 May 2021
Oldest Company Age 5 yrs
Largest company Sahithi Pharma Private Limited · ₹34.27 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sahithi Pharma Private Limited U24110TG2021PTC151302
Director11 May 20212021₹34.27 Cr (FY 2025)Active

Board colleagues of Sridhar Raju Gadiraju

Directorship timeline

Open interactive timeline →
Sahithi Pharma Private Limited
Premium access

Shareholding and investment profile for Sridhar Raju Gadiraju

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sridhar Raju Gadiraju

Sridhar Raju Gadiraju currently holds 1 directorship: Sahithi Pharma Private Limited (Director, since 11 May 2021, revenue ₹34.27 Cr (FY 2025)).

Sridhar Raju Gadiraju was first appointed on 11 May 2021 as Director at Sahithi Pharma Private Limited.

The current boards of Sridhar Raju Gadiraju's companies include Anjaneya Raju Penmetsa (Sahithi Pharma Private Limited), Nagaraju Nadimpally (Sahithi Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available